Role of psoriasis as independent predictor of cardiovascular disease: A meta-regression analysis

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2282-2288

  Gaeta, Maddalena ^a   Castelvecchio, Serenella ^b   Ricci, Cristian ^c   Pigatto, Paolo ^d   Pellissero, Gabriele ^a   Cappato, Riccardo ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Cardiovascular diseases; Infarction; Psoriasis

Indexed keywords

ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; EXPOSURE; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; OBESITY; PREDICTION; PRIORITY JOURNAL; PSORIASIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; VASCULAR DISEASE; CARDIOVASCULAR DISEASES; COMPLICATION; HEALTH; INCIDENCE; META ANALYSIS;

CARDIOVASCULAR DISEASES; GLOBAL HEALTH; HUMANS; INCIDENCE; PSORIASIS; REGRESSION ANALYSIS; RISK FACTORS;

EID: 84885596224     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.197     Document Type: Article

References (60)

1. J.J. Wu, M. Helen Black, and N. Smith Low prevalence of psoriasis among children and adolescents in a large multiethnic cohort in southern California J Am Acad Dermatol 65 5 2011 957 964
2. J.M. Gelfand, R. Weinstein, and S.B. Porter Prevalence and treatment of psoriasis in the United Kingdom Arch Dermatol 141 12 2005 1537 1541
3. B. Dahlof Cardiovascular disease risk factors: epidemiology and risk assessment Am J Cardiol 105 1 Suppl. 2010 3A 9A
4. H. Kremers, M.T. McEvoy, and F.J. Dann Heart disease in psoriasis J Am Acad Dermatol 57 2 2007 347 354
5. M. Esposito, R. Saraceno, and A. Guinta An Italian study on psoriasis and depression Dermatology 212 2 2006 123 127
6. P.A. Russo, R. Ilchef, and A.J. Cooper Psychiatric morbidity in psoriasis: a review Australas J Dermatol 45 3 2004 155 159
7. A.B. Kimball, C. Jacobson, and C. Weiss The psychosocial burden of psoriasis Am J Clin Dermatol 6 6 2005 383 392
8. M. Wakkee, H.B. Thio, and E.P. Prens Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients Atherosclerosis 190 1 2007 1 9
9. J.A. Kaye, L. Li, and S.S. Jick Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis Br J Dermatol 159 2008 895 902
10. M. Wakkee, R.M.C. Herings, and T. Nijsten Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations. Results of a large population-based Dutch cohort J Invest Dermatol 130 2010 962 967
11. N.N. Mehta, R.S. Azfar, and D.B. Shin Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database Eur Heart J 31 8 2010 1000 1006
12. E. Vizzardi, R. Raddino, and M. Teli Psoriasis and cardiovascular diseases Acta Cardiol 65 3 2010 337 340
13. G.A. Vena, M. Vestita, and N. Cassano Psoriasis and cardiovascular disease Dermatol Ther 23 2 2010 144 151
14. J. Xiao, L.H. Chen, and Y.T. Tu Prevalence of myocardial infarction in patients with psoriasis in central China J Eur Acad Dermatol Venereol 23 11 2009 1311 1315
15. Y.B. Brauchli, S.S. Jick, and M. Miret Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis Br J Dermatol 160 5 2009 1048 1056
16. J.A. Kaye, L. Li, and S.S. Jick Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis Br J Dermatol 159 4 2008 895 902
17. R.J. Ludwig, and W.H. Boehncke Psoriasis and risk of myocardial infarction JAMA 297 4 2007 362
18. J.M. Gelfand, A.L. Neimann, and D.B. Shin Risk of myocardial infarction in patients with psoriasis JAMA 296 14 2006 1735 1741
19. W.J. Choi, E.J. Park, and I.H. Kwon Association between psoriasis and cardiovascular risk factors in Korean patients Ann Dermatol 22 3 2010 300 306
20. K. Abuabara, R.S. Azfar, and D.B. Shin Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol 163 3 2010 586 592
21. J.M. Gelfand, R.S. Azfar, and N.N. Mehta Psoriasis and cardiovascular risk: strength in numbers J Invest Dermatol 130 4 2010 919 922
22. A.B. Kimball, and Y. Wu Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis Int J Dermatol 48 11 2009 1147 1156
23. S. Prodanovich, R.S. Kirsner, and J.D. Kravetz Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality Arch Dermatol 145 6 2009 700 703
24. Y. Wu, D. Mills, and M. Bala Psoriasis: cardiovascular risk factors and other disease comorbidities J Drugs Dermatol 7 4 2008 373 377
25. A.B. Kimball, D. Robinson Jr., and Y. Wu Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002 Dermatology 217 1 2008 27 37
26. R.J. Ludwig, C. Herzog, and A. Rostock Psoriasis: a possible risk factor for development of coronary artery calcification Br J Dermatol 156 2 2007 271 276
27. A.L. Neimann, D.B. Shin, and X. Wang Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol 55 5 2006 829 835
28. J.M. Gelfand, R.S. Azfar, and N.N. Mehta Psoriasis and cardiovascular risk: strength in numbers, Part II J Invest Dermatol 131 5 2011 1007 1010
29. D.M. Sommer, S. Jenisch, and M. Suchan Increased prevalence of the metabolic syndrome in patient with moderate to severe psoriasis Arch Dermatol Res 298 2006 321 328
30. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
31. R.M. Harbord, M. Egger, and J.A. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 25 20 2006 3443 3457
32. Review Manager (RevMan) [Computer program] version 5.0 2008 The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen
33. SAS Institute Inc. SAS 9.1.3 help and documentation 2000-2004 SAS Institute Inc. Cary, NC
34. J. Schmitt, and D.E. Ford Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample J Eur Acad Dermatol Venereol 24 8 2010 885 892
35. M. Detmar, L.F. Brown, and K.P. Claffey Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis J Exp Med 180 3 1994 1141 1146
36. W.H. Boehncke, and S. Boehncke Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences G Ital Dermatol Venereol 143 5 2008 307 313
37. T. Henseler, and E. Christophers Disease concomitance in psoriasis J Am Acad Dermatol 32 6 1995 982 986
38. P. Ena, P. Madeddu, and N. Glorioso High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients Acta Cardiol 40 2 1985 199 205
39. C.J. McDonald, and P. Calabresi Psoriasis and occlusive vascular disease Br J Dermatol 99 5 1978 469 475
40. D.J. Pearce, A.E. Morrison, and K.B. Higgins The comorbid state of psoriasis patients in a university dermatology practice J Dermatolog Treat 16 5-6 2005 319 323
41. R.S. Stern, T. Nijsten, and S.R. Feldman Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction J Investig Dermatol Symp Proc 9 2 2004 136 139
42. L. Mallbris, O. Akre, and F. Granath Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients Eur J Epidemiol 19 3 2004 225 230
43. A.W. Evers, E.W. Verhoeven, and F.W. Kraaimaat How stress gets under the skin: cortisol and stress reactivity in psoriasis Br J Dermatol 163 5 2010 986 991
44. P. Gisondi, and G. Girolomoni Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors Semin Thromb Hemost 35 3 2009 313 324
45. R. Mittal, S. Malhotra, and P. Pandhi Efficacy and safety of combination acitretin and pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial Arch Dermatol 145 4 2009 387 393
46. P.M. Okin, S.E. Kjeldsen, and B. Dahlöf Racial differences in incident heart failure during antihypertensive therapy Circ Cardiovasc Qual Outcomes 4 2 2011 157 164
47. S. Jolly, E. Vittinghoff, and A. Chattopadhyay Higher cardiovascular disease prevalence and mortality among younger blacks compared to whites Am J Med 123 9 2010 811 818
48. T.J. Love, A.A. Qureshi, and E.W. Karlson Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006 Arch Dermatol 147 4 2011 419 424
49. O. Karabudak, R.E. Ulusoy, and A.A. Erikci Inflammation and hypercoagulable state in adult psoriatic men Acta Derm Venereol 88 4 2008 337 440
50. B.V. Kural, A. Orem, and G. Cimsit Plasma homocysteine and its relationships with atherothrombotic markers in psoriasis patients Clin Chim Acta 332 2003 23 30
51. M. Milovanovic, E. Nilsson, and P. Jaremo Relationships between platelets and inflammatory markers in rheumatoid arthritis Clin Chim Acta 343 1-2 2004 237 240
52. F. Marongiu, G.G. Sorano, and C. Bibbo Abnormalities of blood coagulation and fibrinolysis in psoriasis Dermatology 189 1 1994 32 37
53. L. Fry, A. Macdonald, and J. Almeyda The mechanism of folate deficiency in psoriasis Br J Dermatol 84 1971 539 544
54. J. Zacho, A. Tybjaerg-Hansen, and B.G. Nordestgaard C-reactive protein and risk of venous thrombo-embolism in the general population Arterioscler Thromb Vasc Biol 30 2010 1672 1678
55. M.J. Grainge, J. West, and T.R. Card Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet 375 2010 657 663
56. T. Saleh, F. Matta, and A.Y. Yaekoub Risk of venous thromboembolism with inflammatory bowel disease Clin Appl Thromb Hemost 17 3 2011 254 258
57. O. Ahlehoff, G.H. Gislason, and J. Lindhardsen Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study PLoS One 25 6(3) 2011 e18125
58. N. Nisa, and M.A. Qazi Prevalence of metabolic syndrome in patients with psoriasis Indian J Dermatol Venereol Leprol 76 6 2010 662 665
59. K.J. Zhu, S.M. He, and L.D. Sun Smoking and psoriasis: a meta-analysis of case-control studies J Dermatol Sci 63 2 2011 126 128
60. R.S. Stern Psoriasis is not a useful independent risk factor for cardiovascular disease J Invest Dermatol 130 4 2010 917 919